logo
AAT Bioquest

Insulin-like growth factor II receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
Mannose 6-phosphateIC5011500.0 [1]
beta-D-Glucose-6-phosphateIC5010000.0 [1]
(Z)-3-(3-Iodo-4-phenoxyphenyl)-2-pyridin-2-ylprop-2-enenitrileIC5046500.0 [1]
[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-[(2-aminobenzoyl)amino]-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphateIC5090.0 [1]
(Z)-3-(4-Hydroxyphenyl)-2-pyridin-2-ylprop-2-enenitrileIC5077100.0 [1]
(Z)-3-(4-Hydroxy-3-methoxyphenyl)-2-pyridin-2-ylprop-2-enenitrileIC503200.0 [1]
[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-amino-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphateIC5020000.0 [1]
[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[(2R,3S)-3-Acetamido-4-[[(2S)-6-acetamido-1-[[(2S,3R)-1-amino-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphateIC501800.0 [1]
Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[12-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxydodecoxy]oxan-2-yl]methyl dihydrogen phosphateIC503700.0 [1]
Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[10-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxydecoxy]oxan-2-yl]methyl dihydrogen phosphateIC504440.0 [1]
Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[8-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoctoxy]oxan-2-yl]methyl dihydrogen phosphateIC505030.0 [1]
Azane;[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-[6-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyhexoxy]oxan-2-yl]methyl dihydrogen phosphateIC504760.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Insulin-like growth factor II receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/insulin-like-growth-factor-ii-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Insulin-like growth factor II receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/insulin-like-growth-factor-ii-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan